Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Log In | Register FREE | Register for Free Webinar | Solution Enquiry | Subscribe
Festival Offer
This Diwali, Light up your portfolio with MoneyWorks4me Superstars starting @ ₹ 7,999 ₹ 5,999 (Offer valid till 3rd Nov 21)

News

Stay Updated! In The World Of Investments!
Sensex 61143.33 206.93 (-0.34%)

Earum Pharmaceutical Latest News

23

Sep, 2021

Earum Pharmaceuticals informs about board meeting

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Earum Pharmaceuticals has informed that a meeting of the Board of Directo...

Read More

07

Sep, 2021

Earum Pharmaceuticals informs about consolidated scrutinizer report

Earum Pharmaceuticals has informed that it enclosed the Consolidated Scrutinizer Report on the Three (3) Resolutions passed at the 9th Annual General Meeting (AGM) of the Company held on Monday, Septem...

Read More

31

Jul, 2021

Earum Pharmaceuticals informs about board meeting

Earum Pharmaceuticals has informed that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of Board of Directors of the Company is scheduled to be held...

Read More

20

Jul, 2021

Earum Pharmaceuticals informs about scrutinizer report

Pursuant to Regulation 44(3) of the SEBI (LODR), Regulations, 2015, Earum Pharmaceuticals has informed that it enclosed Scrutinizer's Report and details regarding voting for the resolutions as emb...

Read More

14

Jul, 2021

Earum Pharmaceuticals informs about compliance certificate

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Earum Pharmaceuticals has informed that it submitted certificate for the quarter ended June 30, 2021 received fro...

Read More

01

Jul, 2021

Earum Pharmaceuticals informs about resignation of CS cum CO

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Earum Pharmaceuticals has informed that Ronak Lalwani has tendered his resignation on...

Read More

05

May, 2020

Earum Pharmaceuticals starts production of Hand Sanitizer, Antiseptic Disinfectant Product

Earum Pharmaceuticals has started production of wide range of Hand Sanitizer in liquid and Gel base and Antiseptic Disinfectant Product Range to fight against COVID-19 at its newly acquired manufacturing unit.

Read More

03

Apr, 2020

Earum Pharmaceuticals gets nod to acquire 55% stake in Cedac Medicorp

Earum Pharmaceuticals has received approval to acquire Cedac Medicorp a partnership firm engaged in manufacturing of Pharmaceutical products. The company proposes to enter into an agreement to acquire its 55% stake ...

Read More

07

Sep, 2019

Earum Pharmaceuticals informs about resignation of director

Earum Pharmaceuticals has informed that Narendrakumar Gangaramdas Patel (DIN:07017438), Non Executive Director of the Company has submitted his letter of resignation dated September 7th, 2019 resigning as Director a...

Read More

20

Aug, 2019

Earum Pharmaceuticals informs about board meeting

Earum Pharmaceuticals has informed that the meeting of Board is scheduled on August, 29th, 2019 at the Corporate office:A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola Ahmedabad 380060 of the Company ...

Read More

Related Earum Pharmaceutical Links: Earum Pharmaceutical Analysis, Earum Pharmaceutical Reports, Earum Pharmaceutical Share Price,
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback